Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Post-thrombectomy angiography-derived fractional flow is associated with functional outcomes in ICAS-related large vessel occlusion.

Journal of neurointerventional surgery·2026
Same author

Endovascular treatment and outcome in patients with CTP-defined extra-large infarct core stroke.

Journal of neurointerventional surgery·2026
Same author

CRKL amplification synergizes with mechanical stress-induced signaling to dually activate YAP oncogenic pathways, driving plantar melanoma progression.

Apoptosis : an international journal on programmed cell death·2026
Same author

Soft chiral-bridged binuclear Pt(II) complexes with cyclometalated N-heterocyclic carbene ligands for multicolor circularly polarized luminescence.

Chemical communications (Cambridge, England)·2026
Same author

Sustainable Synthesis of Ammonium Nitrate From Air and Water via Tandem Plasma-Electrolyzer System.

Angewandte Chemie (International ed. in English)·2026
Same author

Expression patterns and proliferative effect of OTUD6A on Sertoli cells and Leydig cells in cattleyak.

Theriogenology·2026

相关实验视频

Updated: Jun 29, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.2K

治疗帕金森病的细胞重编程疗法.

Wenjing Dong1,2, Shuyi Liu1,2, Shangang Li1,2

  • 1State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan Province, China.

Neural regeneration research
|March 25, 2024
PubMed
概括
此摘要是机器生成的。

细胞重编程为帕金森病治疗提供了一个有前途的新途径,通过再生丢失的神经元来治疗帕金森病. 诸如诱导多能干细胞和直接重编程等策略显示出潜力,解决了早期疗法的局限性.

更多相关视频

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

153
In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

4.9K

相关实验视频

Last Updated: Jun 29, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.2K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

153
In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

4.9K

科学领域:

  • 神经科学是一个神经科学.
  • 再生医学是一种再生医学.
  • 干细胞生物学 干细胞生物学

背景情况:

  • 帕金森病涉及多巴胺能神经元的逐渐丧失.
  • 以前的细胞替代疗法面临着伦理问题和瘤风险.
  • 新的策略旨在克服这些限制,以有效治疗帕金森病.

研究的目的:

  • 审查帕金森病细胞重编程的现状.
  • 专注于诱导多能干细胞 (iPSC) 和直接重编程技术.
  • 讨论临床前和临床进展以及相关的挑战.

主要方法:

  • 对帕金森病模型中的细胞重编程现有文献的审查.
  • 诱导多能干细胞 (iPSC) 治疗的分析,包括临床前和临床数据.
  • 检查纤维细胞和星球细胞直接重新编程成神经元的情况.
  • 在体内重编程争议的讨论.

主要成果:

  • 无论是iPSC还是直接重编程,都显示出对帕金森病治疗的前景.
  • 通过临床前动物模型和早期临床研究,iPSC疗法取得了进展.
  • 直接重新编程提供了一个潜在的替代方案,绕过了伦理和安全方面的担忧.
  • 目前正在进行的研究涉及道德考虑和瘤形成风险.

结论:

  • 细胞重编程策略,包括iPSC和直接重编程,代表了帕金森病治疗的重大进展.
  • 这些方法为克服传统细胞替代疗法的局限性提供了潜在的解决方案.
  • 需要进行进一步的研究和临床试验,才能充分确定帕金森病细胞重编程的安全性和有效性.